Safety and immunogenicity of vesicular stomatitis virus-based vaccines for Ebola virus disease.

de La Vega, Marc-Antoine; Kobinger, Gary P

de La Vega, Marc-Antoine; Kobinger, Gary P.

Afiliação

de La Vega MA; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada.
Kobinger GP; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: gary.kobinger@crchudequebec.ulaval.ca.

Lancet Infect Dis ; 20(4): 388-389, 2020 04.

Article em En | MEDLINE | ID: mdl-31952924

Assuntos

Vacinas contra Ebola; Ebolavirus/imunologia; Doença pelo Vírus Ebola; Estomatite Vesicular; Vesiculovirus; Animais; Método Duplo-Cego

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vesiculovirus / Doença pelo Vírus Ebola / Vacinas contra Ebola / Ebolavirus / Estomatite Vesicular Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google